Olympiad Research’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Olympiad Research's OCDX Position: Q2 2022 in Review
Olympiad Research sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 193,253 shares — an estimated $3.61M sold.
Olympiad Research first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $3.61M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Olympiad Research reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
- Olympiad Research sold 193,253 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.61M.
- Olympiad Research first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
- Olympiad Research's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.61M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.
Based on Olympiad Research's 13F filing for Q2 2022, filed 8 Aug 2022.